Please try another search
TriVascular Technologies, Inc., a medical device company, develops and commercializes technologies to advance minimally invasive treatment of abdominal aortic aneurysms (AAA). The company offers Ovation System, a stent graft platform for the treatment of AAA through minimally invasive endovascular aortic repair. It serves medical professionals and patients. TriVascular Technologies, Inc. was formerly known as TV2 Holding Company and changed its name to TriVascular Technologies, Inc. in November 2013. TriVascular Technologies, Inc. was founded in 1998 and is based in Santa Rosa, California. As of February 3, 2016, TriVascular Technologies, Inc. operates as a subsidiary of Endologix, Inc.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review